Grepafloxacin API is a pharmaceutical-grade fluoroquinolone antibiotic developed for the treatment of susceptible bacterial infections. It acts by inhibiting DNA gyrase and topoisomerase IV, preventing bacterial DNA replication and resulting in effective antibacterial activity against a wide range of Gram-positive and Gram-negative organisms.
Manufactured under WHO-GMP standards, our Grepafloxacin API offers excellent purity, stability, and consistent batch quality suitable for pharmaceutical manufacturing and research applications.
Q1. What is Grepafloxacin API used for?
Grepafloxacin API is used in the development of antibacterial formulations for treating susceptible bacterial infections.
Q2. Is bulk supply available?
Yes. We offer commercial bulk quantities with CoA, MSDS, and complete regulatory documentation.